Overview

The passage of the Inflation Reduction Act (IRA) fundamentally reshaped Medicare drug pricing policy, introducing negotiation authority, benefit redesign, and inflation-based rebates. For global life sciences companies, the law created both financial exposure and strategic uncertainty. A global life sciences client partnered with ADVI Health to translate complex statutory provisions into a practical planning framework to guide portfolio and pricing strategy.

The Challenge

The client needed a clear, structured way to evaluate how IRA provisions could affect in-market and pipeline products. The company sought to:

• Determine potential eligibility and timing under Medicare Drug Price Negotiation
• Estimate exposure under Part D manufacturer discount redesign
• Model inflation rebate liability under various pricing scenarios
• Align global and US teams around a shared understanding of IRA-driven market dynamics

The objective was to move beyond policy interpretation and build a forward-looking strategic tool.

The Strategy

ADVI designed a decision-based, Excel-driven framework grounded in statutory guidance and real-world policy insight.

The tool enables teams to input key product attributes—regulatory pathway, orphan status, benefit type, competitive landscape, pricing assumptions, and exclusivity timelines—and generate tailored scenario outputs across:

• Medicare Drug Price Negotiation – eligibility, timing, and directional Maximum Fair Price (MFP) exposure
• Part D Redesign – statutory discount liability estimates
• Prescription Drug Inflation Rebate Program – projected rebate exposure for price increases above inflation

ADVI supplemented the framework with expert validation and delivered end-user training to ensure adoption and strategic integration.

The Results

The client now has a structured IRA planning engine that:

• Clarifies the timing and magnitude of policy risk
• Supports lifecycle and pricing strategy decisions
• Enhances cross-functional alignment
• Positions the organization to proactively navigate the Medicare market evolution

ADVI transformed legislative complexity into an actionable strategy—enabling confident decision-making in a new policy era.

Learn More

ADVI Health offers expert advice and influential solutions, informed by data and guided by a clear vision of the complex intersection of life sciences and healthcare innovation, economics, policy, and patient impact. Stay ahead of evolving federal drug pricing policy and learn how ADVI can help your organization assess, model, and plan for the strategic impacts of the IRA and other Medicare reforms. Get in touch with our MAPS team to explore customized IRA scenario planning and policy-driven market strategy support.